Evaluation of biological behavior of Toxoplasma gondii atypical isolates # 14 and # 163 by Bernstein, Mariana et al.
Journal Pre-proof
Evaluation of biological behavior of Toxoplasma gondii atypical isolates # 14 and #
163
Mariana Bernstein, Lais L. Pardini, Lucía M. Campero, M. Elisa Helman, Juan M.




To appear in: Experimental Parasitology
Received Date: 19 July 2019
Revised Date: 11 February 2020
Accepted Date: 12 February 2020
Please cite this article as: Bernstein, M., Pardini, L.L., Campero, Lucí.M., Helman, M.E., Unzaga, J.M.,
Venturini, Marí.C., Moré, Gastó., Evaluation of biological behavior of Toxoplasma gondii atypical isolates
# 14 and # 163, Experimental Parasitology (2020), doi: https://doi.org/10.1016/j.exppara.2020.107860.
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition
of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of
record. This version will undergo additional copyediting, typesetting and review before it is published
in its final form, but we are providing this version to give early visibility of the article. Please note that,
during the production process, errors may be discovered which could affect the content, and all legal
disclaimers that apply to the journal pertain.
© 2020 Published by Elsevier Inc.
Credit author statement for “Evaluation of biological behavior of Toxoplasma gondii 
atypical isolates # 14 and # 163” 
Mariana Bernstein: Investigation; Methodology; Writing - Original Draft; Writing - Review & 
Editing  
Lais L. Pardini: Investigation; Validation; Writing - Review & Editing 
Lucía M. Campero: Investigation 
M. Elisa Helman: Formal analysis  
Juan M. Unzaga: Funding acquisition 
María C. Venturini: Funding acquisition; Supervision 




Evaluation of biological behavior of Toxoplasma gondii atypical isolates # 14 and # 163 1 
Mariana Bernstein1, 2*, Lais L. Pardini1, 2, Lucía M. Campero1, 2, M. Elisa Helman1, 2, Juan 2 
M. Unzaga1, María C. Venturini1, Gastón Moré1, 2 3 
 4 
1Laboratorio de Inmunoparasitología (LAINPA), FCV-UNLP, La Plata, Bs. As., Argentina 5 
2 Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina  6 
*Corresponding author: 7 
Mariana Bernstein, Laboratorio de Inmunoparasitología, Universidad Nacional de La Plata, 8 
Facultad de Ciencias Veterinarias, calle 60 y 118 (900) La Plata, Argentina.  9 














ABSTRACT:  23 
Toxoplasma gondii is an obligate intracellular protozoan parasite capable of infecting 24 
warm-blooded animals, including humans. A highly diverse genetic population has been 25 
reported in Central and South America, predominating mainly atypical genotypes. Different 26 
genotypes showed different biological behavior in mice. The aim of this study was to 27 
evaluate the biological behavior of T. gondii isolates obtained from Macropus rufogriseus 28 
(TgMr) and Saimiri boliviensis (TgSb) identified as atypical genotypes # 14 and # 163, 29 
respectively. Strains RH, ME49 and VEG were used as reference for clonal types I, II and 30 
III, respectively. In vitro invasion and replication capacity assays were analyzed at 6 and 18 31 
hpi, respectively. In vivo assay was performed in Swiss mice (n = 30) using 1x102 and 32 
1x103 parasites/mouse as infective doses (ME49, VEG, TgMr, TgSb and negative control). 33 
Morbi-mortality and tissues PCR were assessed. Lymphoproliferation assays were 34 
performed and gamma interferon was measured by ELISA. The ME49 strain showed the 35 
highest invasion, followed by TgSb and VEG, while RH and TgMr presented the lowest 36 
invasions. The RH strain and the TgSb isolate showed more endodyogeny events (fastest 37 
doubling times) than VEG and ME49 strains and the TgMr isolate. Both atypical isolates 38 
showed high virulence (100 % morbi-mortality, at 8-10 dpi) and parasite DNA was 39 
detected in all tissue samples. Splenocytes from mice inoculated with TgMr and TgSb 40 
registered the highest values of gamma interferon. An in vitro invasion-replication index 41 
was established which correlates inversely with virulence in mice. In conclusion, T. gondii 42 
atypical isolates # 14 and # 163 showed a different in vitro behavior than clonal strains, 43 
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 48 
1. INTRODUCTION 49 
Toxoplasma gondii s an obligate intracellular protozoan parasite capable of infecting  50 
warm-blooded animals, including humans (Dubey, 2010). Felines are the definitive hosts 51 
and several species of mammals and birds act as intermediate hosts presenting different 52 
clinical signs (Dubey, 2010). Toxoplasmosis in humans is generally asymptomatic, 53 
however, it may cause a variety of neurological sign  and multi-organic failure in 54 
immunocompromised patients and fetal lesions in the retina (ocular toxoplasmosis), central 55 
nervous system injuries and even abortion in primarily infected pregnant women (Weiss 56 
and Kim, 2014). In the northern hemisphere (Europe, USA and Canada) a predominance of 57 
clonal population of T. gondii has been reported, with clonal type II as dominant (Weiss 58 
and Kim, 2014). However, a highly diverse population has been reported in Central and 59 
South America (especially Colombia, Brazil and Argentina), being detected non-clonal or 60 
atypical genotypes with combinations of types I, II and III alleles, or even new alleles 61 
(Bernstein et al., 2018; Pena et al., 2008; Weiss and Kim, 2014). Different genotypes 62 
showed different biological behavior analyzed mainly in mice model (Dubremetz and 63 
Lebrun, 2012). 64 
Toxoplasma gondii survival relies on its capacity of invasion of new host cells (Weiss and 65 
Kim, 2014). The protozoan multiplies asexually in virtually all nucleated host cells 66 
producing tachyzoites (fast division) or bradyzoites (slow division). The tachyzoites enter 67 
the host cell by an active invasion mechanism, releasing enzymes which produce the 68 
invagination of the host cell membrane. This invagin tion surrounds the tachyzoites and 69 
forms the parasitophorous vacuole (PV) (Weiss and Kim, 2014). After the formation of the 70 
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PV, the tachyzoites multiply by endodyogeny, in which two daughter cells are formed 71 
inside the mother cell. The divisions continue resulting in a geometric expansion of the 72 
parasites until the host cell is destroyed (Dubey et al., 1998). The first in vitro experiments 73 
showed that the tachyzoites of the RH strain (clonal type I) have the highest multiplication 74 
rate while the tachyzoites of the ME49 strain (clonal type II) have the highest invasion rate 75 
(Cañedo-Solares et al., 2013; Contreras-Ochoa et al., 2012; Saadatnia et al., 2010). Some 76 
authors suggest that strain virulence depends on replication capacity more than on invasion 77 
capacity (Cañedo-Solares t al., 2013; Dubremetz and Lebrun, 2012). Similar studies have 78 
been carried out with the protozoan Neospora caninum, closely related to T. gondii 79 
(Dellarupe et al., 2014b). It has been shown that in vitro invasion and replication capacity 80 
can be used as virulence traits in N. caninum and correlated with virulence in mice model 81 
(Dellarupe et al., 2014a, b).  82 
The T. gondii invasion and replication experiments are very heterog neous and most of 83 
them use clonal isolates (Alomar et al., 2013; Cañedo-Solares et al., 2013; Contreras-84 
Ochoa et al., 2012; Cuellar et al., 2012; Malkwitz et al., 2018; Saadatnia et al., 2010). 85 
Therefore, a standard protocol is needed to make results comparable (Contreras-Ochoa et 86 
al., 2012). 87 
Toxoplasma gondii virulence has been defined as the mortality rate in different mice 88 
models (Dubremetz and Lebrun, 2012; Saraf et al., 2017; Sibley and Boothroyd, 1992). 89 
The clonal type I (ToxoDB # 10) is highly virulent in mice, with a LD100 = 1 parasite 90 
(Sibley and Boothroyd, 1992). In contrast, clonal type II is considered as intermediate 91 
virulence with a LD50 ≥ 10
3 parasites (ToxoDB # 1), and clonal type III (ToxoDB # 2) is 92 
considered non-virulent with a LD50 ≥ 10
5 parasites (Sibley and Boothroyd, 1992). Until 93 
now, non-clonal genotypes have shown different virulence in mouse model, leading to 94 
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difficulties on predict virulence based only on genotypes (Dubey, 2010; Dubremetz and 95 
Lebrun, 2012; Weiss and Kim, 2014). The morbidity rates, different degrees of 96 
histopathological lesions, the presence of T. gondii DNA and tissue cysts are associated 97 
with virulence in mouse models (Costa et al., 2018; Pereira et al., 2017; Pinheiro et al., 98 
2015). Immune response in experimentally infected mice is characterized by the production 99 
of IFN-γ (gamma interferon), which induces the development of Th1 profile and 100 
macrophages activation helping to control the parasite proliferation, however paradoxically, 101 
its overproduction has been associated with acute virulence (Chen et al., 2016; Mordue et 102 
al,, 2001; Rodgers et al., 2005; Wang et al., 2016).  103 
Toxoplama gondii genotype # 163 has been frequently detected in Brazil and considered of 104 
variable virulence in mice model (Gennari et al., 2015; Silva et al., 2014). Genotype # 14 105 
has been reported in several South American countries (Argentina, Brazil, Colombia, Chile 106 
and Venezuela) and the USA showing a wider distribution than genotype # 163 (Pardini et 107 
al., 2019). In Brazil, this genotype generated 100 % mortality in mice model, indicating a 108 
highly virulent phenotype (Pena et al., 2008; Rajendran et al., 2012). 109 
The biological behavior of non-clonal T. gondii genotypes in vitro model (expressed as 110 
invasion and replication) and its relation with the virulence in mouse model (expressed as 111 
mortality and morbidity) are still not clear (Dubey, 2010; Dubremetz and Lebrun, 2012; 112 
Weiss and Kim, 2014). It is necessary the establishment of accurate and reliable in vitro 113 
protocols which allow the parasites behavior evaluation and help to reduce, replace and 114 
refine the number of animals for in vivo assays.  115 
The aim of this study was to evaluate the biological behavior of T. gondii isolates identified 116 
as atypical genotypes # 14 and # 163 by in vitro and in vivo studies. Additionally, this study 117 
aimed to establish a relation between the in vitro and in vivo assays results.  118 
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 119 
2. MATERIALS AND METHODS 120 
Toxoplasma gondii solates were obtained from fatal cases of toxoplasmosis in zoo animals 121 
Saimiri boliviensis (Bolivian squirrel monkey) and Macropus rufogriseus (Bennett´s 122 
wallaby) in Argentina (Basso et al., 2007; Pardini et al., 2015), named in this study as TgSb 123 
(genotype # 163) and TgMr (genotype # 14), respectively (Bernstein et al., 2018). 124 
Tachyzoites were maintained in liquid nitrogen and re-isolated in mice deficient for IFN-γ 125 
(GKO; C.129S7 (B6) -ifng˂tm1Ts˃  / J, The Jackson Laboratory, UK) to reduce number of 126 
passages and adaptation to cell culture (Contreras-Ochoa et al., 2012; Dellarupe et al., 127 
2014b). Strains RH, ME49 and VEG were used as referenc  for clonal types I, II and III, 128 
respectively.  129 
2.1 In-vitro invasion and replication assay 130 
This assay was designed based on previous studies from Alomar et al., 2013 and Dellarupe 131 
et al., 2014b. 132 
2.1.1 VERO cell cultures  133 
VERO cells were cultivated with RPMI-1640 medium with glutamine (Gibco, USA), 134 
supplemented with 10 % fetal bovine serum (FBS) (Natocor, Argentina) and 1 % of a 135 
solution of antibiotics and antimycotic (Gibco BRL, UK). All cultures were incubated at 37 136 
ºC with 5 % CO2. 137 
2.1.2 Preparation of tachyzoites   138 
Tachyzoites were harvested when cell monolayer was 80 % infected and the parasites were 139 
inside the PVs. Cell monolayer was detached with a cell scraper (GBO, Germany), and the 140 
suspension was passed through the 22G, 25G and 27½ G needles, to release the parasites 141 
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inside the PVs. Tachyzoites were resuspended in the required infection dose to inoculate 142 
the VERO cultures. All infections were made within 1 h post released of the parasites. 143 
2.1.3 In vitro assay in 24-well plates 144 
The invasion and the amount of produced tachyzoites (replication) were determined in a 145 
24-well plate assay. Circular glass coverslips of 15 mm (MATSUNAMI, Micro Cover 146 
Glass, USA) were placed in 24-well plates, and a concentration of 1x105 VERO cells per 147 
well was added with the conditions described in section 2.1.1. The cell cultures were left 148 
overnight (16 to 18 h), to obtain an 80 % confluent monolayer, and the tachyzoites were 149 
prepared as described in section 2.1.2 and seeded in an infection dose of 1x105/well. Plates 150 
were placed on ice for 10 min to synchronize cell invasion (Alomar et al., 2013). One hour 151 
after infection, the culture medium was changed. Plates were washed with sterile phosphate 152 
buffer solution (PBS) and fixed with cold methanol f r 5 min at -20 °C at 6 and 18 hours 153 
post infection (hpi). Fixed cultures were preserved with sterile PBS at 4 °C. Three 154 
independent experiments were performed for each cut-off time, with 3 replicates each one. 155 
Tachyzoites identification was performed by indirect fluorescent antibody test (IFAT). The 156 
cultures were permeabilized with 0.25 % Triton X100 (Promega, USA) in PBS for 10 min. 157 
Then, PBS with 5 % FBS was added as blocking solution for 30 min. As a primary 158 
antibody a serum from a T. gondii naturally infected goat (with IFAT titer higher than 800), 159 
diluted 1:100 in PBS-0.5 % Tween20 (Metraquímica s.r.l., Argentina) with 0.5 % bovine 160 
serum albumin (BSA, Sigma, USA) was used (Gos et al ., 2017). As secondary antibody 161 
anti-goat IgG conjugated with Alexa 488 fluorochrome (Life technologies, USA) was 162 
diluted 1: 500 in PBS-0.5 % Tween20 and 0.5 % BSA and incubated in the dark. As nuclei 163 
staining, DAPI (4', 6-Diamidino-2-Phenylindole, Dihydrochloride, Molecular Probes, 164 
Invitrogen, USA) was used diluted 1: 2000 in PBS, incubated for 5 min at room 165 
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temperature. All antibodies incubations took place in humid chamber at 37 °C for 45 min 166 
and 3 washes were made after incubations with sterile PBS. Finally, cultures were mounted 167 
with a drop of ~10 µl of mounting fluid MOWIOL 4-88 (Sigma Aldrich, USA) inverting 168 
each coverslip over the mounting fluid, air dried at room temperature overnight and stored 169 
at -20 °C until microscope examination. 170 
Fifty microscopic fields (40X objective) were randomly selected from each coverslip and 171 
the PVs were counted by discriminating among PVs with 1, 2, 4, 8, and 16 tachyzoites. The 172 
invasion was analyzed by the total number of PVs produced by each strain and isolate at 6 173 
hpi. The replication was analyzed by calculating the total amount of parasites that showed 174 
at least one event of endodiogeny (PVs with 2 or more tachyzoites) at 18 hpi for each strain 175 
and isolate.  176 
2.2 Mice bioassay 177 
The experimental design was evaluated and approved by the CICUAL (Institutional 178 
Committee for the Care and Use of Laboratory Animals), Faculty of Veterinary Sciences, 179 
UNLP (protocol 42.6.14T). According their recommendations and to reduce the number of 180 
animals, the RH strain was excluded from the mice bioassay due to its known LD100 = 1 181 
parasite  (Sibley and Boothroyd, 1992). The infective doses of isolates TgMr and TgSb 182 
were defined by a previous trial were all inoculated mice with 1x103 and 1x104 tachyzoites 183 
died with acute toxoplasmosis. A total of 30 specific pathogens free female Swiss mice, of 184 
8 weeks age and 23-29 gr average weight, were used for the assay. Water and food were 185 
provided ad libitum and animals were handled to minimize stress conditi s throughout the 186 
experiment.  187 
Five groups (6 mice/group), were subcutaneously inoculated with the following infection 188 
doses: 1x102 tachyzoites (3 mice/group) and 1x103 tachyzoites (3 mice/group) in each 189 
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group for TgSb (# 163), TgMr (# 14), ME49 and VEG, and with 0.5 ml PBS for the 190 
negative control group (NC). The parasites were maintained in VERO cell cultures as 191 
explained in sections 2.1.1. and 2.1.2.  192 
The mice were monitored daily for 4 weeks, if compatible toxoplasmosis signs were 193 
observed were sacrificed according to the requirements stablished by the CICUAL. 194 
Autopsy was performed and samples of central nervous system (CNS) for histopathology 195 
and PCR, lung for PCR and spleen for lymphoproliferation assay were obtained as detailed 196 
below. Blood samples were obtained by cardiac puncture and sera were stored at -20 °C 197 
until used. 198 
2.2.1 T. gondii DNA identification by PCR 199 
Total DNA extraction was performed from CNS and lung samples with the Wizard® 200 
genomic DNA purification kit, according to the manufacturer's instructions (Promega, 201 
USA). PCR amplification was performed using TOX5-TOX8 primers as previously 202 
described (Pardini et al., 2015). 203 
2.2.2 Histopathology 204 
A portion of the CNS from each mouse was preserved in 10 % buffered formalin. Samples 205 
were processed routinely, stained with hematoxylin and eosin (H&E) and examined 206 
microscopically according to the routine protocols f LAPAVET "Dr. Bernardo Epstein ", 207 
FCV, UNLP. The histopathological lesions were evaluated with the following scoring 208 
scheme: grade 1: mild non-suppurative meningoencephalitis, scarce focal gliosis and scarce 209 
neuronal degeneration; grade 2: moderate non-suppurative meningoencephalitis, 210 
perivascular cuffs; grade 3: non-suppurative and multifocal necrotizing 211 
meningoencephalitis (Venturini et al., 1996). 212 
2.2.3 Anti-T. gondii antibody detection 213 
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Mice sera were diluted in PBS from 1:25 in base 2 and IFAT was performed to final titer. 214 
Samples were considered positive until the last dilution where complete peripheral 215 
fluorescence was observed (Gos et al., 2017). 216 
2.3 Lymphoproliferation assay 217 
2.3.1 Splenocytes cultures 218 
Splenocytes were obtained from a third of each spleen. The organ was smear under laminar 219 
flow and purified by removing the red blood cells using 1 ml of lysis buffer solution (0.83 220 
% ammonium chloride). Cells were counted with 0.5 % trypan blue viability stain in the 221 
Neubauer chamber and seeded onto 96-well culture plat s at a concentration of 2 x 105 222 
viable cells per well in 200 µl of culture medium (Wang et al., 2016). 223 
2.3.2 T. gondii total lysate antigen, stimulation and measure of IFN-γ 224 
The total lysate antigen (TLA) was produced from the T. gondii RH, ME49 and VEG 225 
reference strains and from isolates TgMr and TgSb, maintained in cell cultures as described 226 
in sections 2.1.1 and 2.1.2. The tachyzoites of each strain and isolate were centrifuged 227 
(3000 g, 10 min) and resuspended in 500 µl of sterile PBS. The suspension was sonicated in 228 
3 cycles, 1 min / cycle, at 45W/s (Omni International, USA). The protein content of each 229 
TLA was quantified with a commercial kit (BCA, Pierc , USA) according to the 230 
manufacturer's instructions.  231 
The following treatments were performed in triplicate for each mouse splenocytes 232 
according previous studies (Chen t al., 2016; Wang et al., 2016): 233 
A- Splenocytes seeded in medium with 10 % FBS as negative control. B- Stimulation with 234 
concanavalin A (5 µg / ml; Biorad, USA) as positive control. C- Stimulation with TLA 235 
from the RH strain (10 µg / ml). D- Stimulation with TLA from homologous tachyzoites 236 
(10 µg / ml) (Rodgers et al., 2005). 237 
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Cultures were maintained at 37 °C with 5 % CO2 for 72 h, the supernatants were collected 238 
and stored at -20 °C until use. The IFN-γ was measured using a commercial ELISA kit 239 
(Mouse IFN-γ ELISA Kit, Catalog n°: BMS606; Thermo Fisher Scient fic Inc., USA) 240 
according supplier's instructions, on the pool of the riplicates of each treatment per mouse 241 
splenocytes. 242 
2.4 Statistical analysis 243 
Invasion and replication assay: A Generalized Linear Mixed Model (GLMM) with log link 244 
function was applied. Fixed factor was defined as: strains and isolates, and the response 245 
variables were defined as: number of PVs at 6 hpi and total number of tachyzoites at  and 246 
18 hpi. The experiment effect was considered as a random parameter. When significant 247 
differences were detected, the LSD Fisher test was performed (Balzarini et al ., 2008). 248 
Percentages of PVs with 1, 2, 4, 8, and 16 tachyzoites were calculated for the different T. 249 
gondii strains and isolates at 18 hpi and were plotted as stacked column graphics.  250 
Mice virulence assay: Morbi-mortality was calculated as: total of clinically ill and 251 
sacrificed animals / total of infected animals * 100. Murine IgG anti-T. gondii titers among 252 
the groups were analyzed by Kruskal-Wallis test.  253 
Lymphoproliferation assay: the IFN-γ production values obtained by ELISA were log10 254 
transformed and analyzed by ANOVA and subsequent LSD Fisher. 255 
The Pearson correlation coefficient was used to evaluate the association between the 256 
parameters evaluated in the in vitro assay (invasion and replication) and the morbi-257 
mortality in the in vivo assay. 258 
The InfoStat software version 2018 (Di Rienzo et al., 2008) was used for all statistical 259 
analyzes. The degree of significance was established at p ˂ 0.05 for all analyzes. All the 260 
12 
graphics were generated using the GraphPad Prism software version 7.00 (San Diego, 261 
USA).  262 
 263 
3. RESULTS 264 
3.1 In-vitro invasion and replication assay 265 
Homogeneity among replicates was observed: no significa t differences were found among 266 
the replicates at 6 and 18 hpi ( ˃ 0.05).   267 
Significant differences were found in the invasion capacity between the reference strains 268 
and the atypical isolates analyzed (p ˂ 0.0001). The ME49 strain showed the highest 269 
invasion capacity (p ˂ 0.05), while the TgMr isolate presented the lowest invasion capacity 270 
of all parasites (Figure 1A). 271 
Significant differences were observed in parasite replication,  where the RH strain showed 272 
the highest replication capacity (Figure 1B). 273 
Significant differences were observed in the load an  number of PVs at 18 hpi (p ˂ 0.0001) 274 
according to different strains and isolates. Only the RH strain and the TgSb isolate 275 
produced PVs with 16 tachyzoites (Figure 2). In summary, the RH strain and the TgSb 276 
isolate showed high replication capacity (PVs of 16 tachyzoites = 4 endodyogeny events), 277 
while the VEG and ME49 strains, and the TgMr isolate showed low replication capacity 278 
(PVs of 8 tachyzoites = 3 endodyogeny events). The doubling times were on average ~ 4.5 279 
h for RH and TgSb (18 h / 4 division events) and ~ 6 h for VEG, ME49 and TgMr (18 h / 3 280 
division events).  281 
All strains and isolates had PVs with parasites that did not replicate or had fewer events of 282 
endodyogeny.  The RH strain showed less than 30 % of PVs with 1 tachyzoite and equal 283 
percentages of PVs with 2, 4 and 8 parasites demonstrati g high replication capacity as 284 
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above-mentioned. Also, the TgSb isolate showed high replication capacity but very small 285 
percentages of PVs with 2 to 16 parasites (~ 25 % of PVs). The VEG and ME49 strains, 286 
and the TgMr isolate evidenced ~ 60 % of PVs without replication events (Figure 2).  287 
An index between invasion and replication (invasion-replication index) was established for 288 
each strain and isolate, using the following formula: (average invasion * 18 hpi average 289 
replication) / 1000. The resulting index values were: ME49: 790; VEG: 260; TgSb: 237; 290 
RH: 234; TgMr: 42. 291 
3.4 Mice bioassay  292 
Clinical signs compatible with toxoplasmosis infection (xiphosis, hirsute hair, 293 
conjunctivitis, decay and tachypnea) were observed in all the inoculated mice with the 294 
isolates TgSb (sacrificed at 10 dpi) and TgMr (sacrificed at 8 dpi - inoculated with 103 295 
tachyzoites - and 9 dpi -inoculated with 102 tachyzoites -). Both atypical isolates showed 296 
high virulence (100 % morbi-mortality) in mouse model. Reference strains ME49 and VEG 297 
produced no morbidity, all mice were sacrificed at the end of the assay together with the 298 
NC group. 299 
No correlation was observed between in vitro invasion and mortality (Pearson coefficient 300 
0.19, p ˃ 0.05), nor between i  vitro replication and mortality (Pearson coefficient 0.04, p ˃ 301 
0.05). The in vitro invasion-replication index was inversely related to the mortality 302 
recorded in this assay: the lower value of the in vitro index (isolate TgMr ˂ strain RH ˂  303 
isolate TgSb) the higher mortality (higher virulence) in mice model. 304 
Results from histopathological analysis and presence of T. gondii DNA in mice tissue 305 
samples are showed in Table 1. Out of all CNS from T. gondii inoculated mice (n = 24): 9 306 
presented grade 1 lesions (5 TgSb; 4 ME49), 3 grade 2 (1 ME 49; 2 VEG), 2 grade 3 (2 307 
VEG) and 10 did not present lesions. Different tissue lesions grades are shown in F gure 3.  308 
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All the mice inoculated with T. gondii were seropositive. Antibody titers were higher in 309 
mice inoculated with ME49 (final titer 6400: n 4/6, and 3200, n 2/6) and VEG (final titer 310 
12800, n 6/6), than mice inoculated with TgMr (final titer 50: n 4/6 and 25: n 2/6) and TgSb 311 
(final titer 100; n 4/6 and 50: n 2/6). Differences were significant (p ˂ 0.05). 312 
3.4 Lymphoproliferation assay 313 
The IFN-γ values obtained from splenocytes of mice inoculated with the different strains 314 
and isolates, unstimulated, stimulated with Concanav lin A, stimulated with TLA of RH, 315 
stimulated with homologous TLA and its statistical omparison are shown in Figure 4. 316 
Significance differences were observed among the spl nocytes stimulated with RH TLA, 317 
showing TgMr and TgSb the highest values (p ˂ 0.05). Also, TgMr splenocytes showed the 318 
highest value (p ˂ 0.05) when stimulated with homologous TLA. No significant differences 319 
were detected between homologous TLA and RH TLA stimulation, only TgMr showed an 320 
slightly higher IFN-γ value when challenged with homologous TLA than with the RH TLA. 321 
Results from all the assays are summarized in Table 1.  322 
 323 
4. DISCUSSION 324 
Most studies with T. gondii atypical genotypes biological behavior have focused the 325 
analysis on mice virulence. In this study, we evaluated the in vitro capacity of invasion and 326 
replication of T. gondii atypical isolates in correlation with an in vivo model. We adapted a 327 
methodology previously used in the biological characterization of reference genotypes of T. 328 
gondii and the related protozoan N. caninum (Alomar et al ., 2013; Dellarupe t al., 2014b). 329 
The clonal reference strains in this study showed an in vitro behavior very similar to that 330 
described by other researchers (Cañedo-Solares et al., 2013; Saadatnia et al., 2010). The 331 
clonal type I (RH = virulent) showed low invasion capacity but high replication capacity, 332 
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while the clonal type II (ME49 = intermediate virulence) showed high invasion capacity, 333 
but low replication capacity (Cañedo-Solares et al., 2013; Saadatnia et al., 2010). On the 334 
other hand, clonal type III (VEG = non virulent), presented intermediate invasion and low 335 
replication, similar to what was previously described (Malkwitz et al., 2018). The doubling 336 
time of the RH strain tachyzoites was slightly faster than that recorded in previous studies 337 
(Cañedo-Solares et al., 2013), which could be related to limited cell cuture adaptation and 338 
strain re-isolation in mice (Contreras-Ochoa et al., 2012; Dellarupe t al., 2014b). Malkwitz 339 
et al., 2018, reported the ME49 replication values in Vero cells higher than NED strain 340 
(clonal type III) after 12 hpi., using  qPCR. In our study, the ME49 strain showed an active 341 
behavior at the beginning of infection (high invasion at 6 hpi), but low and slow replication 342 
(most PVs only with 1 or 2 tachyzoites at 18 hpi), in contrast with the clonal type III (VEG 343 
strain) that showed low replication capacity but PVs even with 8 tachyzoites. The in vitro 344 
behavior we observed in the ME49 and VEG strains could be associated with its reported 345 
mice virulence, where a low and slow replication would allow the infected cells survival 346 
and the establishment of an effective immune respone (Dubremetz and Lebrun, 2012; 347 
Mordue et al., 2001; Sibley and Boothroyd, 1992). The atypical so ate TgMr (# 14) had an 348 
in vitro behavior similar to the RH strain with respect to its low invasion capacity (even 349 
lower than RH), however, it had the lowest replication of all strains and isolates used in the 350 
assay. On the other hand, the atypical isolate TgSb (# 163) had an intermediate invasion 351 
capacity (similar to VEG strain) and a high replication (similar to RH strain). Despite the 352 
fact that the capacity and the intrinsic mechanism of invasion by reference strains (mainly 353 
RH) has been extensively evaluated (Contreras-Ochoa et al., 2012; Dubey et al., 1998; 354 
Dubremetz and Lebrun, 2012; Weiss and Kim, 2014), the results of the present study 355 
suggest it is negatively related to virulence.. In addition, considering our results, the 356 
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capacity of invasion and possibly its intrinsic mechanism, could not be fully extrapolated 357 
between different T. gondii strains.  358 
It has been stated that the clonal strains virulence correlates with high replication capacity 359 
(Cañedo-Solares et al., 2013; Dubremetz and Lebrun, 2012; Malkwitz e  al., 2018). Based 360 
on our results, the RH strain and TgSb isolate showed the highest speeds (or the lowest 361 
doubling times), the replication and the "speed" of division correlates positively with 362 
virulence. Invasion and replication capacity have be n used as phenotypic virulence traits 363 
for N. caninum isolates (Dellarupe t al., 2014b) and were useful in this work to evaluate 364 
the behavior of clonal and atypical T. gondii isolates. Nevertheless, the total amount of 365 
intracellular parasites for TgMr and TgSb were lower than the three reference strains, 366 
suggesting that there may be other virulence factors n t directly associated with invasion 367 
and replication. In summary, the atypical isolates of T. gondii obtained from M. rufogriseus 368 
and S. boliviensis have a different in vitro behavior than the clonal reference strains, 369 
showing invasion and replication characteristics similar to the virulent RH clonal type, 370 
respectively.  371 
Both atypical isolates showed 100 % morbi-mortality, using doses as low as 1x102 372 
tachyzoites, similar as previously described using similar atypical isolates (Gennari et al., 373 
2015; Pardini et al., 2019; Pena et al., 2008; Rajendran et al., 2012; Rego et al., 2017; Silva 374 
et al., 2014). Probably the use of a lower parasite dose could help to identify possible 375 
virulence differences, as suggested by other authors (Saraf et al ., 2017). On the other hand, 376 
mice infected with clonal strains (ME49 and VEG) had a 0 % morbi-mortality and were 377 
considered as non-virulent (Mordue et al., 2001; Sibley and Boothroyd, 1992). 378 
Mice infected with atypical genotypes, showed absence (TgMr) or low severity (TgSb) of 379 
CNS lesions, possibly due to sacrifice in the acute stage of the infection (8-10 dpi) as 380 
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reported by others (Mordue t al., 2001; Pinheiro et al., 2015). Despite of this, T. gondii 381 
DNA was detected in all CNS and lung samples, confirming the presence of the parasites. 382 
Mice infected with ME49 and VEG strains showed no clini al signs, however, severe 383 
lesions in the CNS were detected, which could be related to a cell-mediated response 384 
controlling the excessive multiplication of protozoa (Weiss and Kim, 2014). These mice 385 
were considered chronically infected as confirmed by the tissue cysts observation in CNS 386 
(Dubey, 2010). In addition, 5/6 and 2/6 mice infected with ME49 resulted positive to T. 387 
gondii DNA in CNS and lung, respectively, possibly due to the preferential location in 388 
CNS of the chronic stages of the infection (Costa et l., 2018; Dubey, 2010). As expected 389 
for non-lethal clonal strains, tachyzoites multiplication was controlled by the host immune 390 
system and protozoa were confined to CNS cells as br dyzoites (Pinheiro et al., 2015). 391 
Additionally, the differences in the IgG titers obtained in this study could be associated 392 
with the time of infection (Dubey, 2010). 393 
In our study, the isolate with the genotype # 163, was characterized as virulent, both in in 394 
vitro and in the in vivo assays, similar as reported for one of the isolates from Rego et al., 395 
(2017). It seems that the same genotype could present differences in virulence and therefore 396 
the biological behavior could not be 100 % predictable from the molecular markers used in 397 
this work (Rego et al., 2017). Similar to other studies, our results indicate that isolate with 398 
the genotype # 14, is characterized as virulent (Pardini et al., 2019; Pena et al., 2008; 399 
Rajendran et al., 2012).  400 
As a final goal, mice cellular (IFN-γ) immune response was evaluated. In both cases, the 401 
isolates TgMr and TgSb induced a higher IFN-γ production than clonal strains ME49 and 402 
VEG, similar to what has been described by other authors (Chen et al., 2016; Wang et al., 403 
2016). The extremely high IFN-γ production from infected mice splenocytes (especially 404 
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with TgMr), could indicate a greater number of effector lymphocytes. These results agree 405 
with those reported by other researchers in which hig  levels of IFN-γ were detected in 406 
lethal infections (RH strain), whereas moderate levls were detected in non-lethal infections 407 
(Mordue et al., 2001). Therefore, the adaptive immune response gen rated by these atypical 408 
isolates could contribute to the pathogenesis and the fatal outcome of toxoplasmosis 409 
(Mordue et al., 2001; Weiss and Kim, 2014). It has been suggested that the T. gondii strain 410 
used to prepare the TLA affects the cytokines produce  by lymphocytes in vitro (Rodgers 411 
et al., 2005). Our results indicate that all TLA stimulated splenocytes produced similar 412 
amounts of INF-Ꝩ. In general, splenocytes stimulated with TLA from RH, produced 413 
slightly higher concentrations with the exception of those stimulated with homologue of 414 
TgMr. It is probable that the TgMr isolate expresses different antigens recognized as 415 
virulence factors, such as rhoptry proteins, which could induce an overproduction of IFN-γ 416 
in infected animals (Dubremetz and Lebrun, 2012; Rodgers et al., 2005). Splenocytes were 417 
collected at the time of sacrifice which differed between atypical isolates and clonal strains 418 
(ME49 and VEG) leading to potential differences. Probably more accurate results could be 419 
obtain performing this assay at fix time, however, it equires a higher number of infected 420 
mice and the use of non-lethal dose or strains, which is not always possible with highly 421 
virulent atypical strains. In summary, the overproduction of IFN-γ in mice infected with 422 
TgMr and TgSb could be related to the expression / secretion of immune response 423 
modulators by these protozoa and could be associated wi h the higher virulence detected in 424 
the in vivo model (Dubremetz and Lebrun, 2012; Mordue et al., 2001; Rodgers et al., 425 
2005). On the other hand, the evaluation of the humoral response (IgG titers) did not allow 426 
comparisons since blood sampling was conducted at different times. Futures studies aiming 427 
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humoral response evaluation should considerer sampling at fix time (Chen et al., 2016; Tao 428 
et al., 2013).   429 
Finally, an in vitro invasion-replication index was established that could correlate with 430 
virulence and mice morbi-mortality inversely (Table 1). The RH strain and the atypical 431 
isolates, presented the lowest index values, mainly due to a low invasion. The lower 432 
invasion-replication index was associated with the higher virulence, although a larger 433 
number of strains and isolates should be evaluated to confirm this assumption. Other 434 
factors not measured in the in vitro assay may possibly be influencing virulence such as the 435 
expression and allelic profiles of ROP proteins (Dubremetz and Lebrun, 2012). In the same 436 
way, CS3 is a useful marker to predict the virulence of T. gondii in the "atypical" isolates 437 
from Brazil (Silva et al., 2014). It would be interesting to analyze the mentioned molecular 438 
markers in a higher number of isolates, including atypical isolates obtained from Argentina.  439 
It would be important to evaluate the in vitro behavior of other phylogenetically related T. 440 
gondii atypical isolates in order to confirm the usefulness of the assay presented here as 441 
complement / substitute to mouse model experiments. Al o, performing the protocols 442 
described in this study with different cell lines, could allow the improvement of virulence 443 
prediction and the design of comparable studies (Contreras-Ochoa et al., 2012). The 444 
validation of an in vitro invasion-replication index could be useful to indirectly predict 445 
virulence in mice.  446 
In conclusion, the T. gondii atypical isolates # 14 and # 163 resulted in a different in vitro 447 
behavior than clonal strains, with low invasion-replication indexes, but showing high 448 
virulence in mice model in association with high levels of INF-Ꝩ. 449 
 450 
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Figure captions: 567 
Figure 1. In vitro assay: Invasion values (number of parasitophorous vacuoles at 6 hpi, A) 568 
and replication values (number of tachyzoites at 18 hpi, B) for each T. gondii strain and 569 
isolate. Different letters indicate significant differences (p ˂ 0.05, LSD Fisher). Reference: 570 
PVs = parasitophorous vacuoles.  571 
Figure 2. In vitro assay: Comparison of the percentages of PVs of 1, 2, 4, 8 and 16 572 
tachyzoites for each T. gondii strain and isolate at18 hpi. Reference: PVs = parasitophorous 573 
vacuoles.  574 
Figure 3. In vivo assay: Representative photomicrographs of T. gondii infected mice CNS 575 
sections showing different grades of lesions (H&E staining). Grade 1: Neural necrosis 576 
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(arrow), 40x (A, mouse inoculated with TgSb). Grade 2: mild non-suppurative focal 577 
meningitis (arrow), 20x (B, mouse inoculated with VEG). Grade 3: numerous mononuclear 578 
cells, focal gliosis (arrow), 20x (C, mouse inoculated with VEG). Two large cysts in 579 
cerebellum without inflammatory reaction (arrow), 40x (D, mouse inoculated with VEG). 580 
Scale bars = 100 µm. 581 
Figure 4. Lymphoproliferation assay: production values of IFN-γ by splenocytes of mice 582 
inoculated with the different T. gondii strains and isolates, unstimulated (A, black), 583 
stimulated with Concanavalin A (B, orange), stimulated with TLA of RH (C, purple) and 584 
homologous TLA (D, gray). Values obtained by ELISA (pg/ml) were log10 transformed to 585 
apply an ANOVA. Different letters indicate significant differences among the columns with 586 
the same color (p ˂ 0.05). 1 Note: stimulation with Concanavalin A of splenocytes from 587 
mice infected with TgMr exceeded the IFN-γ detection values from ELISA kit. 588 
 589 
Table 1. Summary of the results from the in vitro and the in vivo assays with different T. gondii strains and isolates.   
References:  
a: Invasion: average number of PVs at 6 hpi.  
b: Replication: average number of the total amount of parasites that showed at least one event of endodiogeny (PVs with 2 or more tachyzoites) at 18 hpi.  
c: Invasion-replication index: (average invasion 6 hpi * average replication 18 hpi) / 1000. 
d: Morbi-mortality: total of clinically ill and sacrificed animals / total of infected animals * 100. 
e: Mice inoculated with 1x103 tachyzoites were sacrificed 8 dpi, while mice inoculated with 1x102 tachyzoites were sacrificed 9 dpi. 
f: Number of mice with CNS lesions / number of mice inoculated. 
g: Number of mice with T. gondii cysts in CNS / number of mice inoculated. 
h: Number of mice with T. gondii DNA detection in CNS / number of mice inoculated. 
i: Number of mice with detection of T. gondii DNA in lung / number of mice inoculated. 
j: Average values obtained from splenocytes stimulated with TLA from RH/and homologous TLA. Values were log10 transform for statistical analysis. Original average values 
obtained by ELISA (pg/ml) between brackets.  
k: IFAT final titers: number of mice with IgG final titer / number of mice inoculated.   
dpi: days post infection. 
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• In vitro and in vivo behavior of 2 T. gondii atypical isolates was evaluated.  
• Atypical isolates showed similar in vitro behavior to the virulent type I strain. 
• Atypical isolates showed 100 % morbi-mortality in mice with a 102 parasites.  
• High virulence was associated with high IFN- in lymphoproliferation assay. 
• Low values of invasion-replication index correlated with high virulence in mice.  
 
